Gene expression analysis of established cell lines, patient-derived tumor xenografts (PDTXs), and patient tumors suggest that FOXC2-driven VM is prevalent in aggressive sub-types of many solid tumors regardless of tissue of origin. Here, FOXC2 is linked to neoplasm.